-->

HTRF Human CCL22 Detection kit HTRF®

The HTRF Human CCL22 kit is designed for the quantification of human CCL22 release in cell supernatant.

See more
  • Low sample consumption Low sample consumption
  • No-wash No-wash
  • Faster and more convenient than ELISA Faster and more convenient than ELISA

The HTRF Human CCL22 kit is designed for the quantification of human CCL22 release in cell supernatant.

-

Overview

CCL22 (C-C motif chemokine 22), previously referred to as Macrophage-derived chemokine (MDC),  is a chemokine secreted by dendritic cells (DC), macrophages, and activated B-lymphocytes.  CCL22 binds to CCR4 present in many different cell types.

CCL22 is secreted by M2 macrophages, which contribute to Th2 responses such as phagocytosis, tissue repair, and wound healing.

Through its binding to CCR4, CCL22 has also been shown to contribute to the pathogenesis of atopic diseases, like asthma and atopic dermatitis (AD).

Assessment of serum samples often requires enhanced sensitivity. In some cases, AlphaLISA assays may have sufficient sensitivity to enable the detection of low levels of analytes in serum or plasma. Check out the  Human CCL22 AlphaLISA kit’s analytical performances for more information or learn more about AlphaLISA. When assaying, always follow the recommended protocol and avoid highly haemolyzed samples.

Benefits

  • VALIDATED ON PBMC
  • PANEL QUANTIFICATION

Assay principle

Cell supernatant, sample, or standard is dispensed directly into the assay plate for the detection by HTRF® reagents (384-well low-volume white plate or PerkinElmer low-volume 96-well plate in 20 µl). The antibodies labeled with the HTRF donor and acceptor are pre-mixed and added in a single dispensing step, to further streamline the assay procedure. The assay can be run in up to a 1536-well format by simply resizing each addition volume proportionally.

protocol of the HTRF CCL22 assay

Assay data analysis

The 4 Parameter Logistic (4PL) curve is commonly recommended for fitting an ELISA standard curve. This regression enables the accurate measurement of an unknown sample across a wider range of concentrations than linear analysis, making it ideally suited to the analysis of biological systems like cytokine releases.  To fully understand how to deal with HTRF data processing and also 4PL 1/y² fitting, please visit this page.  Cisbio also works with Myassays.com to help you in your data analysis. By clicking on this link, you’ll be able to access a free online software to run your CCL22 analysis.

Technical specifications of human CCL22 kit

Sample size

16 µL

Final assay volume

20 µL

Kit components

Lyophilized standard, frozen detection antibodies, buffers & protocol.

LOD &LOQ (in Diluent)

5.7 pg/mL & 7.9 pg/mL

LOD &LOQ (in RPMI)

9.8 pg/mL & 16.8 pg/mL

LOD &LOQ (in DMEM)

7.7 pg/mL & 13.8 pg/mL

Range

35 – 4,000 pg/mL

Time to result

4h to Overnight at RT

Species

Human only

Intra and inter assay

Intra-assay (n=24)

Sample

Mean [CCL22] (pg/mL)

CV

1

584

9%

2

284

4%

3

139

7%


Mean CV

6%

Each of the 3 samples was measured 24 times, and % CV was calculated for each sample.

Inter-assay (n=4)

Sample

Mean [CCL22] (pg/mL)

CV

1

560

7%

2

396

9%


Mean CV

9%

​​​​​​​Each of the samples was measured in 4 different experiments, and % CV was calculated for each sample.

Dilutional linearity

Sample

Dilution factor

[CCL22] expected (pg/mL)

[CCL22] detected (pg/mL)

Recovery

1

1

-

584

-

2

292

284

97%

4

142

139

98%

Mean

97%

2

1

-

1168

-

2

584

584

100%

4

292

262

90%

Mean

95%

The excellent % of recovery obtained from these experiments show the good linearity of the assay.


Spike recovery

Different amounts of recombinant cytokine (P1, P2 or P3) were added to 2 different PBMC supernatant stimulated samples (S1 and S2).

The set of responses obtained from a standard curve was compared to the calculated expected values. The ~ 100% of recovery observed validates the sample matrix used for this assay.

RPMI

recomb prot (pg/ml)

expected (pg/ml)

obtained (pg/ml)

% Recovery

S1 Native

0

_

596

_

S1-P1 spike

845

1440

1520

95%

S1-P2 spike

401

997

1040

96%

S1-P3 spike

167

763

817

93%

mean

95%

S2 Native

0

_

350

_

S2-P1 spike

845

1194

1096

109%

S2-P2 spike

401

751

734

102%

Mean

105%

CCL22 secretion in PBMC cells stimulated with PHA-P and PHA-M

PBMC cells plated at 200 and 300 kcells/well were stimulated for 72 h with PHA-P and PHA-M respectively, used at 10 µg/mL.

 16 µL of supernatants were then transferred into a white detection plate (384 low volume) and 4 µL of the HTRF Human CCL22  detection reagents were added. The HTRF signal was recorded after an overnight incubation at room temperature.

The standard curve prepared in RPMI allowed the estimation of the CCL22 concentration in each sample. The results showed that PHA-M stimulated more CCL22 secretion than PHA-P. Little CCL22 was detected in the non-stimulated sample.

Standard curve of human CCL22 in RPMI
CCL22 estimation with HTRF human CCL22  in PBMC cells stimulated or not with PHA-P and PHA-M

Calibration with Other Technologies

Different densities of PBMC cells were stimulated for 48 or 72 h with 10 µg/mL of PHA-P. The CCL22 concentration of the different samples (pure and diluted) was estimated using the HTRF Human CCL22 detection kit, the AlphaLISA human CCL22 detection, and an ELISA assay.

For the HTRF assay, 16 µL of the different cell supernatants were then transferred into a white detection plate (384 low volume) and 4 µL of the HTRF Human CCL22  detection reagents were added. The HTRF signal was recorded after an overnight incubation at room temperature.

For the AlphaLISA assay, 5 µL of cell supernatants were transferred into a grey detection plate (384w plate) and 45µL of detection reagents were added. The AlphaLISA counts were recorded after a 3h incubation at room temperature.

The AlphaLISA human CCL22 detection assay and the HTRF human CCL22 detection kit gave the same concentration estimation for each sample, while the ELISA assay estimated concentration values only half those estimated by the HTRF and AlphaLISA assays.


CCL22 versus competition

Cytokine assays: a guide to success with HTRF

Setting up a successful cytokine assay - Guides

Portfolio of Life Sciences Cytokine Assays

This leaflet presents the analytical performances of each assay - Brochures

Product Insert CCL22 (h) Kit / 62HCCL22PEG-62HCCL22PEH

62HCCL22PEG-62HCCL22PEH - Product Insert

Plate Reader Requirement

Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.

Let's find your reader